Medline Inc. Class A common stock (MDLN)

Price$48.26

Favorite Metrics

Price vs S&P 500 (4W)2.00%

Market Capitalization$62.58B

P/E Ratio (Annual)54.00x

All Metrics

P/CF (Annual)35.89x

Book Value / Share (Quarterly)$8.17

Revenue Growth (3Y)9.85%

Price vs S&P 500 (YTD)9.29%

Gross Margin (TTM)26.44%

Net Profit Margin (TTM)4.08%

EPS (TTM)$1.28

10-Day Avg Trading Volume5.49M

EPS Excl Extra (TTM)$1.28

EPS (Annual)$1.43

ROI (Annual)4.97%

Gross Margin (Annual)26.44%

Cash / Share (Quarterly)$1.48

P/E Basic Excl Extra (TTM)54.00x

P/E Normalized (Annual)54.00x

ROA (Last FY)3.01%

EBITD / Share (TTM)$3.03

Operating Margin (TTM)7.78%

Cash Flow / Share (Annual)$0.99

P/B Ratio5.83x

P/B Ratio (Quarterly)4.97x

Net Income / Employee (Annual)$0

Net Interest Coverage (TTM)2.39x

EPS Incl Extra (Annual)$1.43

Current Ratio (Annual)4.29x

Quick Ratio (Quarterly)2.37x

3-Month Avg Trading Volume7.05M

EV / Free Cash Flow (Annual)56.44x

P/E Incl Extra (TTM)54.00x

Revenue / Employee (TTM)$1

P/S Ratio (Annual)2.20x

Asset Turnover (Annual)0.74x

52-Week High$50.88

EPS Excl Extra (Annual)$1.43

Quick Ratio (Annual)2.37x

13-Week Price Return9.74%

Total Debt / Equity (Annual)1.17x

Current Ratio (Quarterly)4.29x

Enterprise Value$73,206.355

Revenue / Employee (Annual)$1

Pretax Margin (Annual)4.39%

Cash / Share (Annual)$1.48

3-Month Return Std Dev37.25%

Net Income / Employee (TTM)$0

ROE (Last FY)10.79%

Net Interest Coverage (Annual)2.39x

EPS Basic Excl Extra (Annual)$1.43

P/FCF (TTM)48.25x

EV / Free Cash Flow (TTM)56.44x

Total Debt / Equity (Quarterly)1.17x

EPS Incl Extra (TTM)$1.28

P/S Ratio (TTM)2.20x

Revenue / Share (Annual)$35.01

Forward P/E32.96x

P/E Ratio (TTM)54.00x

Year-to-Date Return13.43%

5-Day Price Return0.89%

EPS Normalized (Annual)$1.43

Net Profit Margin (Annual)4.08%

Month-to-Date Return7.06%

EBITD / Share (Annual)$3.51

Operating Margin (Annual)7.78%

LT Debt / Equity (Annual)1.16x

P/CF (TTM)35.89x

P/E Excl Extra (TTM)54.00x

LT Debt / Equity (Quarterly)1.16x

EPS Basic Excl Extra (TTM)$1.28

P/B Ratio (Annual)4.97x

Pretax Margin (TTM)4.39%

Book Value / Share (Annual)$8.17

Price vs S&P 500 (13W)6.88%

Beta1.60x

P/FCF (Annual)48.25x

Revenue / Share (TTM)$33.50

52-Week Low$34.89

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

4.19

4.18

Industry Peers — Surgical & Medical Instruments(108)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
MDLNMedline Inc. Class A common stock	2.20x	—	26.44%	7.78%	$48.26
SYKStryker Corporation	5.17x	11.84%	64.57%	19.43%	$338.34
BSXBoston Scientific Corp.	4.58x	15.16%	69.01%	18.00%	$60.99
MMM3M Company	3.21x	-4.97%	39.92%	18.55%	$151.40
BDXBecton, Dickinson and Co.	2.06x	6.32%	46.42%	12.15%	$158.64
RMDResMed Inc.	6.07x	11.72%	60.85%	33.70%	$226.14
DXCMDexCom, Inc.	5.33x	19.33%	62.09%	19.56%	$64.62
WSTWest Pharmaceutical Services, Inc.	6.29x	7.44%	35.91%	19.03%	$278.00
PODDInsulet Corporation	5.19x	24.53%	71.63%	12.92%	$200.87
PENPenumbra, Inc.	9.24x	20.16%	67.14%	13.48%	$329.71
GMEDGLOBUS MEDICAL INC	4.37x	30.08%	67.41%	20.33%	$96.82

About

Medline is the largest medical-surgical products and supply chain solutions provider in the United States, generating over 90% of its revenue domestically. The company serves major US health systems as a prime vendor, offering approximately 190,000 proprietary products and 150,000 third-party sourced products through an integrated supply chain. Backed by 30+ manufacturing facilities and over 2,000 owned delivery trucks, Medline leverages significant operational scale and logistics advantages. The company completed its IPO in December 2025.